Literature DB >> 10744952

High-level expression of tetanus toxin fragment C-thioredoxin fusion protein in Escherichia coli.

A V Ribas1, P L Ho, M M Tanizaki, I Raw, A L Nascimento.   

Abstract

An insert of Clostridium tetani DNA corresponding to fragment C of tetanus toxin was amplified by PCR. This 1.4 kb fragment was cloned into the high-expression vector pET32a, under control of the T7 promoter. Expression of this plasmid in Escherichia coli BL21(DE3) resulted in the production of a fusion protein ( approximately 62 kDa) consisting of 112 amino acids of thioredoxin and approximately 450 amino acids of fragment C. This fusion protein was recognized by anti-tetanus toxoid antiserum in an ELISA and on immunoblots. The recombinant fragment-C-thioredoxin protein was purified significantly in one step by Ni(2+)-chelate Sepharose, the final yield being approximately 35 mg/l. Immunization of animals with the recombinant protein produced antibodies that were able to recognize the tetanus toxin. By using this gene-fusion expression system we produced soluble fragment C of tetanus toxin in a high yield, preventing many problems inherent in the use of other expression systems that produce either insoluble fragment C in inclusion bodies, or a soluble form, but in low yield, using E. coli as the expression host.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744952     DOI: 10.1042/ba19990084

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  6 in total

1.  Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.

Authors:  Patrícia A E Abreu; Patrícia A Miyasato; Mônica M Vilar; Waldely O Dias; Paulo L Ho; Míriam Tendler; Ana L T O Nascimento
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Transgenic tomatoes express an antigenic polypeptide containing epitopes of the diphtheria, pertussis and tetanus exotoxins, encoded by a synthetic gene.

Authors:  Ruth Elena Soria-Guerra; Sergio Rosales-Mendoza; Crisóforo Márquez-Mercado; Rubén López-Revilla; Rosalba Castillo-Collazo; Angel Gabriel Alpuche-Solís
Journal:  Plant Cell Rep       Date:  2007-02-16       Impact factor: 4.570

3.  Tetanus toxin fragment C fused to flagellin makes a potent mucosal vaccine.

Authors:  Shee Eun Lee; Chung Truong Nguyen; Soo Young Kim; Thinh Nguyen Thi; Joon Haeng Rhee
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

4.  An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo.

Authors:  Eduardo Aliprandini; Daniela Yumi Takata; Ana Lepique; Jorge Kalil; Silvia Beatriz Boscardin; Ana Maria Moro
Journal:  Toxicon X       Date:  2019-01-18

Review 5.  Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.

Authors:  Caroline Bayart; Angélique Mularoni; Nada Hemmani; Soumeya Kerachni; Joachim Jose; Patrice Gouet; Joseph Paladino; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-17

6.  Safety and Immunogenicity of a Recombinant Tetanus Vaccine in Healthy Adults in China: A Randomized, Double-Blind, Dose Escalation, Placebo- and Positive-Controlled, Phase 1/2 Trial.

Authors:  Xiaowei Xu; Rui Yu; Lanlan Xiao; Jie Wang; Meihong Yu; Junjie Xu; Yajun Tan; Xiao Ma; Xiaoxin Wu; Jiangshan Lian; Kaizhou Huang; Xiaoxi Ouyang; Sheng Bi; Shipo Wu; Xiaoyan Wang; Jiandi Jin; Ling Yu; Huafen Zhang; Qi Wei; Jinfa Shi; Wei Chen; Lanjuan Li
Journal:  Adv Sci (Weinh)       Date:  2021-06-03       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.